DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $130.8 million versus the consensus estimate of $123.74 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.